HighTower Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.3M Sell
300,011
-74,167
-20% -$20.5M 0.06% 300
2026
Q1
$111M Buy
374,178
+21,256
+6% +$6.31M 0.12% 178
2025
Q4
$96.4M Sell
352,922
-908
-0.3% -$247K 0.11% 194
2025
Q3
$95.6M Sell
353,830
-7,532
-2% -$2.05M 0.11% 190
2025
Q2
$99.6M Sell
361,362
-3,047
-0.8% -$829K 0.12% 174
2025
Q1
$96.7M Sell
364,409
-12,892
-3% -$3.18M 0.13% 168
2024
Q4
$87.6M Sell
377,301
-4,946
-1% -$1.14M 0.12% 178
2024
Q3
$84.3M Sell
382,247
-5,590
-1% -$1.16M 0.12% 183
2024
Q2
$76.3M Sell
387,837
-13,779
-3% -$2.85M 0.12% 183
2024
Q1
$86.5M Buy
401,616
+23,414
+6% +$4.92M 0.14% 166
2023
Q4
$79.6M Buy
378,202
+9,372
+3% +$2M 0.13% 164
2023
Q3
$73.8M Sell
368,830
-18,504
-5% -$3.68M 0.14% 157
2023
Q2
$71.8M Buy
387,334
+68,793
+22% +$12.7M 0.14% 160
2023
Q1
$61M Sell
318,541
-1,662
-0.5% -$301K 0.13% 178
2022
Q4
$53.9M Sell
320,203
-45,770
-13% -$7.95M 0.12% 184
2022
Q3
$64.8M Buy
365,973
+19,780
+6% +$3.91M 0.17% 131
2022
Q2
$70.8M Buy
346,193
+30,076
+10% +$6.38M 0.18% 125
2022
Q1
$75.2M Buy
316,117
+2,485
+0.8% +$584K 0.17% 125
2021
Q4
$71.7M Buy
313,632
+13,349
+4% +$2.94M 0.16% 144
2021
Q3
$58.1M Buy
300,283
+154,275
+106% +$31.3M 0.16% 140
2021
Q2
$31.1M Sell
146,008
-11,578
-7% -$2.44M 0.09% 230
2021
Q1
$32.2M Buy
157,586
+2,618
+2% +$516K 0.1% 204
2020
Q4
$28.2M Buy
154,968
+44,668
+40% +$7.6M 0.12% 179
2020
Q3
$18.5M Buy
110,300
+4,881
+5% +$822K 0.09% 221
2020
Q2
$17.1M Buy
105,419
+827
+0.8% +$148K 0.09% 220
2020
Q1
$18.1M Sell
104,592
-6,947
-6% -$1.38M 0.12% 181
2019
Q4
$22.4M Buy
111,539
+26,465
+31% +$5.43M 0.13% 172
2019
Q3
$18M Sell
85,074
-1,605
-2% -$335K 0.1% 210
2019
Q2
$16.8M Buy
86,679
+463
+0.5% +$85.4K 0.1% 219
2019
Q1
$14.2M Sell
86,216
-1,038
-1% -$184K 0.09% 228
2018
Q4
$16.4M Sell
87,254
-12,536
-13% -$2.31M 0.13% 172
2018
Q3
$17M Sell
99,790
-9,127
-8% -$1.54M 0.12% 183
2018
Q2
$17.9M Sell
108,917
-163
-0.1% -$26.6K 0.14% 162
2018
Q1
$17.6M Sell
109,080
-12,764
-10% -$2.03M 0.15% 144
2017
Q4
$17.8M Sell
121,844
-11,621
-9% -$1.66M 0.15% 146
2017
Q3
$18.1M Buy
133,465
+537
+0.4% +$67.8K 0.15% 144
2017
Q2
$16.7M Buy
132,928
+4,056
+3% +$485K 0.15% 151
2017
Q1
$15.3M Buy
128,872
+6,054
+5% +$728K 0.15% 141
2016
Q4
$14.2M Buy
122,818
+6,097
+5% +$678K 0.15% 139
2016
Q3
$12.2M Buy
116,721
+81,568
+232% +$8.52M 0.14% 145
2016
Q2
$3.42M Sell
35,153
-2,745
-7% -$259K 0.04% 449
2016
Q1
$3.63M Sell
37,898
-1,060
-3% -$96.4K 0.01% 491
2015
Q4
$3.53M Buy
38,958
+4,186
+12% +$394K 0.04% 425
2015
Q3
$3.22M Buy
+34,772
New +$3.31M 0.04% 447
2015
Q2
Sell
-38,634
Closed -$3.66M 1619
2015
Q1
$3.66M Buy
38,634
+706
+2% +$65.4K 0.05% 394
2014
Q4
$3.36M Buy
37,928
+6,154
+19% +$522K 0.05% 404
2014
Q3
$2.54M Sell
31,774
-5
-0% -$377 0.04% 464
2014
Q2
$2.25M Buy
31,779
+43
+0.1% +$3.03K 0.04% 530
2014
Q1
$2.35M Buy
31,736
+93
+0.3% +$7.01K 0.05% 463
2013
Q4
$2.48M Sell
31,643
-24,374
-44% -$1.91M 0.05% 399
2013
Q3
$4.14M Buy
+56,017
New +$4.13M 0.1% 230

Other funds holding CME

HighTower Advisors's CME Position: Q2 2026 in Review

HighTower Advisors reduced its CME Group (CME) stake by 20% in Q2 2026, selling an estimated $20.5M and leaving 300,011 shares worth $66.3M. The position accounts for 0.06% of the portfolio, ranked #300.

HighTower Advisors first reported a position in CME in Q3 2013 and has held it in 51 quarters since. The position peaked at $111M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • HighTower Advisors held 300,011 shares of CME Group worth $66.3M as of Q2 2026.
  • HighTower Advisors sold 74,167 CME Group shares in Q2 2026, an estimated $20.5M.
  • CME Group made up 0.06% of HighTower Advisors's portfolio in Q2 2026, its #300 holding.
  • HighTower Advisors first reported a position in CME Group in Q3 2013 and has held it in 51 quarters since.
  • HighTower Advisors's CME Group position peaked at $111M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.